Salary
Advice & Tips
Calculate Your Salary Ranking
56
 
30
 
85
 
98
Home > Peregrine Pharmaceuticals Salary

Peregrine Pharmaceuticals Salary

Peregrine Pharmaceuticals average salary is $86,992, median salary is $86,992 with a salary range from $48,984 to $125,000.
Peregrine Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Peregrine Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
48,984
Average
86,992
Median
86,992
High
125,000
Total 2 Peregrine Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Other 48,984-48,984 Tustin, CA, 92780 2012 Peregrine Pharmaceuticals Other Salaries (1)
Peregrine Pharmaceuticals Tustin, CA Salaries
Sr. Clinical Trials Manager 125,000-125,000 Tustin, CA, 92780 2011 Peregrine Pharmaceuticals Sr. Clinical Trials Manager Salaries (1)
Peregrine Pharmaceuticals Tustin, CA Salaries
1
Peregrine Pharmaceuticals Jobs
See more Peregrine Jobs »
Peregrine Pharmaceuticals Salary News & Advice
See more Salary Advice »
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Peregrine Pharmaceuticals Salaries (July 27, 2014)
Other Peregrine Pharmaceuticals $48,984 Tustin, CA, 92780 09/19/2012

Peregrine Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Peregrine Pharmaceuticals Information
  • Peregrine Pharmaceuticals
  • Industry: BioTech/Drugs
  • City: Tustin, CA
  • Peregrine Pharmaceuticals Inc (NASDAQ: PPHM ) is a biotechnology company focused on the research, development and commercialization of novel cancer th
  • Peregrine Pharmaceuticals Profile
  • Steven King